BAKER BROS ADVISORS LLC Insider Trading for January 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of BAKER BROS ADVISORS LLC for January 2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 29 2016 | BCRX | BIOCRYST PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 6.88 | 25,000 | 172,015 | 12,641,525 | 12.6 M to 12.6 M (+0.20 %) |
Jan 29 2016 | BCRX | BIOCRYST PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 6.98 | 63,345 | 441,971 | 12,616,525 | 12.6 M to 12.6 M (+0.50 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 11.00 | 3,581 | 39,377 | 6,502,773 | 6.5 M to 6.5 M (+0.06 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 11.00 | 395 | 4,343 | 778,047 | 777.7 K to 778 K (+0.05 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.80 | 66,345 | 716,745 | 6,499,192 | 6.4 M to 6.5 M (+1.03 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.80 | 7,318 | 79,059 | 777,652 | 770.3 K to 777.7 K (+0.95 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 11.20 | 2,522 | 28,257 | 6,432,847 | 6.4 M to 6.4 M (+0.04 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 11.20 | 278 | 3,115 | 770,334 | 770.1 K to 770.3 K (+0.04 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.98 | 4,503 | 49,423 | 6,430,325 | 6.4 M to 6.4 M (+0.07 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.98 | 497 | 5,455 | 770,056 | 769.6 K to 770.1 K (+0.06 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 11.23 | 2,833 | 31,822 | 6,425,822 | 6.4 M to 6.4 M (+0.04 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 11.23 | 312 | 3,505 | 769,559 | 769.2 K to 769.6 K (+0.04 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.69 | 25,650 | 274,219 | 6,422,989 | 6.4 M to 6.4 M (+0.40 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.69 | 2,810 | 30,041 | 769,247 | 766.4 K to 769.2 K (+0.37 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.60 | 156 | 1,654 | 6,397,339 | 6.4 M to 6.4 M (0.00 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.60 | 17 | 180 | 766,437 | 766.4 K to 766.4 K (0.00 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.69 | 4,021 | 42,999 | 6,397,183 | 6.4 M to 6.4 M (+0.06 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.69 | 440 | 4,705 | 766,420 | 766 K to 766.4 K (+0.06 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.78 | 17,221 | 185,666 | 6,393,162 | 6.4 M to 6.4 M (+0.27 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.78 | 1,887 | 20,345 | 765,980 | 764.1 K to 766 K (+0.25 %) |
Jan 25 2016 | BCRX | BIOCRYST PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.00 | 3,200 | 22,389 | 12,553,180 | 12.5 M to 12.6 M (+0.03 %) |
Jan 25 2016 | BCRX | BIOCRYST PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.29 | 103,600 | 755,368 | 12,549,980 | 12.4 M to 12.5 M (+0.83 %) |
Jan 20 2016 | BCRX | BIOCRYST PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 6.94 | 1,325 | 9,197 | 12,446,380 | 12.4 M to 12.4 M (+0.01 %) |
Jan 20 2016 | BCRX | BIOCRYST PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 6.87 | 51,370 | 352,974 | 12,445,055 | 12.4 M to 12.4 M (+0.41 %) |
Jan 20 2016 | BCRX | BIOCRYST PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.12 | 92,200 | 656,750 | 12,393,685 | 12.3 M to 12.4 M (+0.75 %) |
Jan 20 2016 | BCRX | BIOCRYST PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.49 | 25,000 | 187,333 | 12,301,485 | 12.3 M to 12.3 M (+0.20 %) |
Jan 20 2016 | BCRX | BIOCRYST PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.45 | 175,000 | 1,303,890 | 12,276,485 | 12.1 M to 12.3 M (+1.45 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.90 | 1,734 | 15,433 | 6,375,941 | 6.4 M to 6.4 M (+0.03 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.90 | 190 | 1,691 | 764,093 | 763.9 K to 764.1 K (+0.02 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.96 | 27,996 | 250,766 | 6,374,207 | 6.3 M to 6.4 M (+0.44 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.96 | 3,067 | 27,472 | 763,903 | 760.8 K to 763.9 K (+0.40 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.96 | 13,789 | 123,493 | 6,346,211 | 6.3 M to 6.3 M (+0.22 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.96 | 1,511 | 13,532 | 760,836 | 759.3 K to 760.8 K (+0.20 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 9.89 | 57,453 | 567,934 | 6,332,422 | 6.3 M to 6.3 M (+0.92 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 9.89 | 6,294 | 62,217 | 759,325 | 753 K to 759.3 K (+0.84 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 9.15 | 14,313 | 131,017 | 6,274,969 | 6.3 M to 6.3 M (+0.23 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 9.15 | 1,568 | 14,353 | 753,031 | 751.5 K to 753 K (+0.21 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 9.21 | 10,123 | 93,282 | 6,260,656 | 6.3 M to 6.3 M (+0.16 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 9.21 | 1,109 | 10,219 | 751,463 | 750.4 K to 751.5 K (+0.15 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 9.08 | 45,903 | 416,602 | 6,250,533 | 6.2 M to 6.3 M (+0.74 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 9.08 | 5,029 | 45,642 | 750,354 | 745.3 K to 750.4 K (+0.67 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.56 | 47,193 | 403,930 | 6,204,630 | 6.2 M to 6.2 M (+0.77 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.56 | 5,196 | 44,473 | 745,325 | 740.1 K to 745.3 K (+0.70 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.95 | 4,949 | 44,308 | 6,157,437 | 6.2 M to 6.2 M (+0.08 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.95 | 545 | 4,879 | 740,129 | 739.6 K to 740.1 K (+0.07 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.82 | 3,279 | 28,937 | 6,152,488 | 6.1 M to 6.2 M (+0.05 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.82 | 361 | 3,186 | 739,584 | 739.2 K to 739.6 K (+0.05 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.10 | 20,851 | 168,891 | 6,149,209 | 6.1 M to 6.1 M (+0.34 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.10 | 2,296 | 18,597 | 739,223 | 736.9 K to 739.2 K (+0.31 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.08 | 2,998 | 24,213 | 6,128,358 | 6.1 M to 6.1 M (+0.05 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.08 | 330 | 2,665 | 736,927 | 736.6 K to 736.9 K (+0.04 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.91 | 12,706 | 100,517 | 6,125,360 | 6.1 M to 6.1 M (+0.21 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.91 | 1,399 | 11,067 | 736,597 | 735.2 K to 736.6 K (+0.19 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.17 | 90,550 | 739,947 | 6,112,654 | 6 M to 6.1 M (+1.50 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.17 | 9,970 | 81,472 | 735,198 | 725.2 K to 735.2 K (+1.37 %) |